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PCongenital Heart Disease
Aortic Valve Reinterventions After Balloon
Aortic Valvuloplasty for Congenital Aortic Stenosis
Intermediate and Late Follow-Up
David W. Brown, MD, Amy E. Dipilato, BS, Erin C. Chong, BS, James E. Lock, MD,
Doff B. McElhinney, MD
Boston, Massachusetts
Objectives The aim of this study was to evaluate the long-term results of transcatheter balloon aortic valvuloplasty, the pre-
ferred treatment for congenital aortic stenosis (AS).
Background Aortic valve function and reintervention late after this procedure are not well characterized.
Methods From 1985 to 2008, 563 patients underwent balloon dilation for congenital AS. After excluding those converted to
univentricular circulation and/or died 30 days after the procedure, 509 patients constituted the study cohort.
Results The median follow-up period was 9.3 years (range 0.1 to 23.6 years); cumulative follow-up was 5,003 patient-
years. The median age was 2.4 years (range 1 day to 40.5 years), and most patients (73%) had isolated native
AS. Peak AS gradients decreased significantly after dilation (median decrease, 35 mm Hg), and acute post-
dilation aortic regurgitation was moderate or greater in 70 patients (14%). Older patients more often had post-
dilation aortic regurgitation (p  0.001). During follow-up, 225 patients (44%) underwent aortic valve reinterven-
tion: repeat balloon dilation in 115 (23%), aortic valve repair in 65 (13%), and aortic valve replacement in 116
(23%). Survival free from any aortic valve reintervention was 89  1% at 1 year, 72  2% at 5 years, 54  3%
at 10 years, and 27  3% at 20 years. Freedom from aortic valve replacement was 90  2% at 5 years, 79 
3% at 10 years, and 53  4% at 20 years. In multivariate analyses, lower post-dilation AS gradient and lower
grade of post-dilation aortic regurgitation were associated with longer freedom from aortic valve replacement,
but age, era, and pre-dilation AS severity were not.
Conclusions Although transcatheter aortic valvuloplasty is effective for relief of congenital AS, there are steady long-term haz-
ards for surgical aortic valve reintervention and replacement that are independent of age at initial intervention
or AS severity. (J Am Coll Cardiol 2010;56:1740–9) © 2010 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.06.040a
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wirst reported 26 years ago (1), balloon aortic valvuloplasty
as become the preferred treatment for newborns, children,
nd young adults with congenital aortic stenosis (AS) at
ost centers (2–12). Factors associated with technical
uccess and short-term and midterm outcomes of balloon
alvuloplasty for congenital AS have been characterized in a
umber of studies (2–4,6,10,11,13,14). However, there is
imited information on the long-term function of the aortic
alve or the frequency of or risk factors for aortic valve
eplacement (AVR) or other forms of aortic valve reinter-
ention after balloon dilation (9,12). The objective of this
etrospective cohort study was to characterize freedom from
rom the Department of Cardiology, Children’s Hospital, and Department of
ediatrics, Harvard Medical School, Boston, Massachusetts. This study was sup-
orted by the Higgins Family Fund. All authors have reported that they have no
elationships to disclose. This retrospective study was performed according to a protocol
pproved by the Committee for Clinical Investigation at Children’s Hospital Boston.o
Manuscript received February 17, 2010; revised manuscript received May 27, 2010,
ccepted June 16, 2010.ortic valve reinterventions and patient-related and proce-
ural risk factors for reintervention in a large cohort of
atients treated over a 24-year period.
See page 1750
ethods
atients. Patients with diagnoses of congenital valvular AS
ho underwent transcatheter balloon valvuloplasty at Chil-
ren’s Hospital Boston from December 1984 through
anuary 2009 were ascertained from the computer database
f the Department of Cardiology. Patients who died or were
onverted to functionally univentricular circulation within
0 days of catheterization were excluded. Patients who
nderwent aortic valve reintervention within 30 days and
urvived with biventricular circulation were included. Pa-
ients with associated congenital cardiovascular anomalies
ere included, as were those who underwent prior surgical
r transcatheter aortic valve intervention before referral to
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November 16, 2010:1740–9 Aortic Valve Reintervention in Congenital ASur center. Patent ductus arteriosus in newborns, patent
oramen ovale, and atrial septal defects not treated surgically
ere not counted as “associated cardiovascular anomalies.”
ndications for catheterization and valve dilation were not
tandardized and may have varied according to patient age,
linical status, era, referring physician, and catheterizing
hysician. General guidelines for intervention considered
ymptomatic status, AS gradient, ventricular function, and
he presence and severity of associated anomalies. From
985, balloon dilation was the first-line therapy for congen-
tal AS at our center, and surgical aortic valvotomy would
ave been performed almost exclusively in patients with
oexisting anomalies requiring open heart surgery or for
nsuccessful balloon dilation. Cross-sectional follow-up was
btained by June 2009.
A subset of patients in this cohort were included in
revious reports detailing left-heart adequacy in neonates
ith AS and left-heart growth, function, and reintervention
fter neonatal balloon aortic valve dilation (11,13). These
atients were included in the present study primarily to
llow assessment of the relationship between age at inter-
ention and long-term valve-related outcomes.
ortic valve function. Pre-intervention AS severity was
easured as the peak systolic gradient recorded in the
atheterization laboratory using simultaneous (preferen-
ially) or pullback pressure recordings. Pre-intervention
radient was captured as a continuous variable and also
rouped into categories according to thresholds used in the
econd Joint Study on the Natural History of Congenital
eart Defects (49, 50 to 79, and 80 mm Hg) (15).
cute post-intervention AS gradient was reported as the
eak gradient measured at the end of the procedure by
imultaneous or pullback pressure measurement. Post-
ntervention gradients were grouped into clinically relevant
ategories according to inflections in the receiver-operating
haracteristic curve for gradient and aortic valve reinterven-
ion (time-independent). Aortic regurgitation (AR) was
raded angiographically as none, trace (trivial), mild (1),
nd moderate through severe (2, 3, and 4), also
eferenced as moderate-severe.
alloon dilation of the aortic valve. The technical details
f aortic valve dilation have been described previously
2,3,6). Our general approach is to begin dilation with a
alloon diameter 90% of the diameter of the aortic
nnulus and to progress with higher pressure inflation of the
ame balloon and/or larger balloons as necessary to achieve
n adequate therapeutic approach. Of course, balloon,
atheter, and guidewire technology evolved over the course
f this experience, so the equipment used varied over time,
ith balloons and wires conforming with current technol-
gy. Other technical variations, such as antegrade dilation
nd rapid ventricular pacing, were used variably at the
iscretion of the various operators. In general, the goal is to
educe the peak gradient as low as possible without causing
R. In situations in which a borderline residual gradient is mresent (30 to 40 mm Hg, de-
ending on circumstances), the
ecision to proceed with addi-
ional dilation is based in part on
he change in AR, if any, up to
hat point. AR was typically eval-
ated after balloon inflation, after
atheter pullback for assessment of
esidual AS, using aortography in
he ascending aorta.
ata analysis. The primary outcome measure was freedom
rom AVR among patients surviving 30 days after inter-
ention with biventricular circulation. Secondary outcome
easures included freedom from repeat balloon aortic
alvuloplasty, freedom from surgical aortic valve reinterven-
ion, and survival free from these different forms of reinter-
ention. Time-to-event analyses were performed both as
urvival free from reintervention, with both death and
eintervention treated as events, and as freedom from
eintervention, with event-free censoring of patients who
ied. Kaplan-Meier analysis with log-rank testing and Cox
roportional hazards regression were performed to assess
he relationship between predictor variables and time to
vent. The start time was set at 30 days after dilation; for the
urposes of analysis, any reinterventions that occurred
efore 30 days after dilation were considered to occur at
ime 0. Multivariate Cox regression was performed with
orward stepwise entry of predictor variables significant at
 0.05 on univariate analysis, with adjustment for era
procedure date quartile). Predictor variables included pro-
edure date order (analyzed by quartile), age (continuous)
nd age group at initial catheterization, isolated native AS
no associated anomalies and no prior interventions), prior
ortic valve interventions elsewhere, additional cardiac
nomalies, severity of AS before intervention, residual AS
radient measured in the catheterization laboratory after
alloon dilation, and degree of acute AR measured in the
atheterization laboratory. Predictor variables not specially
entioned in the “Results” section were not significantly
ssociated with the outcome of interest. For Kaplan-Meier
nalysis of freedom from repeat balloon dilation, patients
ere censored event free at the time of aortic valve surgery
f applicable. Competing risks analysis was also performed,
ith AVR, death, and survival without AVR as the out-
omes. The change in peak AS gradient after dilation was
ssessed by Wilcoxon signed rank test. Between-group
omparisons of continuous variables were performed by
-way analysis of variance, and assessment of differences
etween categorical variables was performed using chi-
quare analysis. Unless otherwise specified, data are pre-
ented as mean  SD or as median (range). Hazard ratios
HRs) are presented with 95% confidence intervals (CIs).
ecause questions relating to survival in this cohort are the
ocus of a separate ongoing study, only a limited analysis of
Abbreviations
and Acronyms
AR  aortic regurgitation
AS  aortic stenosis
AVR  aortic valve
replacement
HR  hazard ratioortality was performed.
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Aortic Valve Reintervention in Congenital AS November 16, 2010:1740–9esults
atients. Between 1984 and 2008, 563 patients with con-
enital AS underwent balloon aortic valvuloplasty at Chil-
ren’s Hospital Boston. Fifty-four of these patients were
xcluded from the present study because they were con-
erted to functionally univentricular circulation during the
ame hospitalization, either as part of a planned strategy of
eft-heart rehabilitation or because of circulatory insuffi-
iency after aortic valve dilation (n  35), and/or died
ithin 30 days of the balloon dilation (n  19). The
emaining 509 patients constituted the study cohort. De-
ographic and diagnostic details of these 509 patients are
ummarized in Table 1. Pre-intervention AS gradients are
ummarized in Table 2.
The median duration of clinical follow-up (as opposed to
imply vital status) was 9.3 years (range 0.1 to 23.6 years).
ltogether, 5,003 patient-years of clinical follow-up was
btained. Among patients who underwent balloon dilation
efore 2006, clinical follow-up data were available for at
east 2 years or until the time of death in all but 6 patients.
mong more recent patients, none were definitely lost to
ollow-up (defined as no clinical information for 4 years),
lthough in 6 patients, the most recent follow-up was 2
onths after dilation.
emographic and Diagnostic Data at the Time ofirst Intervention Amo g 509 Early (30-Day)urvivors of B lloon Aortic Valvuloplasty forongenital AS, 1984 to 20 8
Table 1
Demographic and Diagnostic Data at the Time of
First Intervention Among 509 Early (30-Day)
Survivors of Balloon Aortic Valvuloplasty for
Congenital AS, 1984 to 2008
Variable Value
Age, median (range) 2.4 yrs (1 day to 40.5 yrs)
Age group
1 month 113 (22%)
1–12 months 119 (23%)
1–10 yrs 135 (27%)
11–15 yrs 92 (18%)
16 yrs 50 (10%)
Associated congenital cardiovascular anomalies
None 370 (73%)
Coarctation of the aorta 80 (16%)
Mitral stenosis* 51 (10%)
Multiple left-heart obstructions† 38 (8%)
Ventricular septal defect 41 (8%)
Interrupted aortic arch 12 (2%)
Other‡ 3 (1%)
Prior interventions
None 367 (72%)
Prior intervention for AS 75 (15%)
Surgical valvotomy 57 (11%)
Balloon dilation 21 (4%)
Coarctation/interrupted arch repair 70 (14%)
Ventricular septal defect closure 22 (4%)
Subaortic stenosis procedure 20 (4%)
Defined as mean transmitral Doppler gradient 4 mm Hg. †AS plus at least 2 of the following:
oarctation of the aorta, mitral stenosis, subaortic stenosis. ‡One case each of transposition of the
reat arteries, tetralogy of Fallot, and sinus venous atrial septal defect with partially anomalous
ulmonary venous return.
AS  aortic stenosis.urvival. Forty-four patients died during follow-up. Sur-
ival over time was 95 1% at 5 years, 93 1% at 10 years,
nd 88  2% at 20 years by Kaplan-Meier analysis, with a
teep early hazard for death followed by a steady hazard
Fig. 1).
cute results of balloon dilation. Peak AS gradients
ecreased significantly after balloon dilation, with a median
ecrease of 35 mm Hg (p  0.001). The distribution of
re-intervention and post-intervention gradients and post-
ntervention AR is summarized in Table 2 and Figure 2.
lder patients (the oldest 2 age groups combined) were
ignificantly more likely have moderate or severe AR than
ounger patients (p 0.001). Neonates had significantly lower
esidual gradients (p  0.001). There was no clear association
etween residual gradient and the severity of AR.
Figure 1 Competing Risks Outcome Curve
Competing risks outcome curve shows the prevalence of death, aortic valve
replacement (AVR), and survival without AVR among 509 patients with congeni-
tal aortic stenosis who survived more than 30 days after balloon dilation with
biventricular circulation.
re-Intervention and Acute Post-Intervention Aorticalve Function Among 509 Early (30-Day) Survivorsf Balloo A rtic Valvuloplasty for Congenital AS,984 to 2008
Table 2
Pre-Intervention and Acute Post-Intervention Aortic
Valve Function Among 509 Early (30-Day) Survivors
of Balloon Aortic Valvuloplasty for Congenital AS,
1984 to 2008
Variable Value
Pre-intervention peak AS gradient (mm Hg)
Median (range) 65 (6–160)
49 71 (14%)
50–79 301 (59%)
80 135 (27%)
Acute post-dilation peak AS gradient (mm Hg)*
Median (range) 28 (0–106)
29 259 (51%)
30–39 140 (28%)
40 108 (21%)
Acute post-dilation AR severity*
None-trace 262 (52%)
Mild 175 (34%)
Moderate or severe 70 (14%)
Data missing on 2 patients.
AR  aortic regurgitation; AS  aortic stenosis.
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November 16, 2010:1740–9 Aortic Valve Reintervention in Congenital ASortic valve reintervention. During follow-up, 225 of the
09 patients surviving 30 days with biventricular circula-
ion underwent 338 reinterventions on the aortic valve
Table 3). Survival free from any aortic valve reinterven-
ion was 89  1% at 1 year, 72  2% at 5 years, 54  3%
t 10 years, 38  3% at 15 years, and 27  3% at 20 years
Fig. 3).
epeat balloon dilation. A total of 149 repeat balloon
ortic valve dilation procedures were performed in 115
atients, 5 of which were within 30 days of the initial
rocedure. Kaplan-Meier survival free from repeat balloon
alvuloplasty after the index procedure was 90  1% at 1
ear, 82 2% at 5 years, 71 3% at 10 years, and 63 4%
t 20 years (Fig. 4). Factors associated with shorter survival
ree from repeat balloon dilation on multivariate Cox
egression included age 30 days at intervention (HR: 5.3;
5% CI: 3.6 to 7.9; p  0.001) and higher residual AS (per
0 mm Hg) early after intervention (HR: 1.21; 95% CI:
.07 to 1.35; p  0.002).
urgical aortic valve reintervention. Surgical interven-
ions on the aortic valve were performed in 159 patients,
ncluding aortic valvuloplasty (16) in 65 and AVR in 116
Table 3). Forty-nine of these patients had undergone
Figure 2 Distribution of Post-Balloon Dilation AR
Bar charts depict the distribution of post-dilation aortic regurgitation (AR) by age g
post-dilation aortic stenosis (AS) gradients at catheterization according to the seveecond balloon dilations before aortic valve surgery. Survival Aree from any surgical aortic valve reintervention was 82 
% at 5 years, 69 3% at 10 years, 58 3% at 15 years, and
5  4% at 20 years. Freedom from aortic valve surgery
deaths censored event free) was essentially identical: 82 
% at 5 years, 69 3% at 10 years, 59 3% at 15 years, and
6  4% at 20 years. Results of Cox regression analysis for
reedom from surgical aortic valve reintervention are sum-
nd
post-dilation AR.
ortic Valve Reinterventionsmong 509 Early (30-Day) Survivorsf BAVP for Congenital AS, 1984 to 2008
Table 3
A rtic Valve Reinter entions
Among 509 Early (30-Day) Survivors
of BAVP for Congenital AS, 1984 to 2008
Intervention/Reintervention
Number of Patients
(Procedures)
Any reintervention on the aortic valve 225 (338)
Repeat BAVP 115 (149)
Multiple repeat BAVP procedures 30
Surgical aortic valve reintervention 159 (192)
Surgical aortic valve repair 65 (65)
Aortic valve replacement 116 (127)
Pulmonary autograft 53
Mechanical valve prosthesis 52
Homograft aortic root replacement 8
Bioprosthetic valve 3roup a
rity ofS  aortic stenosis; BAVP  balloon aortic valvuloplasty.
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Aortic Valve Reintervention in Congenital AS November 16, 2010:1740–9arized in Table 4. Predictors of shorter freedom from
urgical reintervention on multivariate analysis included
igher acute post-dilation AS gradient, higher grade of
cute post-dilation AR, and the presence of multiple left-
eart obstructive lesions; on univariate analysis, procedure
ate order quartile was not associated with freedom from
ortic valve surgery, but when forced into the multivariate
odel, freedom from aortic valve surgery was shorter in the
ost recent quartile of patients undergoing balloon
alvuloplasty.
VR. AVR was performed in 116 patients, 21 of whom
ad previously undergone surgical aortic valve repair. The
rimary indication for AVR was mixed AR and left ven-
ricular outflow tract obstruction (both at least moderate) in
7 patients, left ventricular outflow tract obstruction (AS
nd/or subvalvular obstruction) in 27 patients, AR in 23
atients, and unknown in 9 patients (followed elsewhere,
imited records available). Survival free from AVR was 86
% at 5 years, 74 3% at 10 years, 62 3% at 15 years, and
7  4% at 20 years. The results of a competing risks
nalysis of AVR, death, or survival without AVR are
epicted in Figure 1. Freedom from AVR (deaths censored
vent free) was 90  2% at 5 years, 79  3% at 10 years,
7  3% at 15 years, and 53  4% at 20 years. The results
f Cox regression analysis for freedom from surgical aortic
alve reintervention are summarized in Table 4. Age group
to 10 years, isolated native AS, absence of multiple
eft-heart obstructive lesions, no aortic valve interventions
efore treatment at our center, lower post-intervention
radient, and lower grade of post-intervention AR were
ssociated with longer freedom from AVR on univariate
ox regression analysis (representative Kaplan-Meier curves
re shown in Fig. 5). Factors associated with longer freedom
rom AVR on multivariate Cox regression included lower
Figure 3 Freedom From Any Aortic Valve Reintervention
Kaplan-Meier curve depicts freedom from any aortic valve reintervention among
509 patients with congenital aortic stenosis who survived more than 30 days
after balloon dilation with biventricular circulation.cute post-dilation AS gradient and lower grade of acuteost-dilation AR (Table 4, Fig. 5). Notably, freedom from
VR did not differ across our experience (procedure order
uartile) and by univariate analysis was shorter in patients
ge 16 years and 11 to 15 years at the time of aortic valve
ilation than in neonates, infants, and young children (age
to 10 years).
nteractions between residual AS and post-dilation AR.
n our initial multivariate model, we tested interaction
ffects with AR grade entered as an ordinal variable (grades
to 4) and post-dilation AS gradient entered as a contin-
ous variable, with no interaction effect reaching signifi-
ance. To further explore the interaction between post-
ilation AR and residual AS gradient, we empirically
rouped patients into 6 categories on the basis of the
ombination of post-dilation AR severity (none-trivial,
ild, moderate-severe) and acute residual AS gradient as
easured in the catheterization laboratory (35 mm Hg,
35 mm Hg). The gradient cutoff was selected as the center
f the clinically challenging 30 to 40 mm Hg range. This
ariable was then entered into multivariate analysis of
reedom from AVR along with AR severity on an ordinal
cale (grades 0 to 4) and residual AS gradient as a contin-
ous variable. According to this model, the combined
ariable was significantly associated with freedom from
VR, whereas post-dilation AR and residual AS gradient
lone were not (Fig. 6). HRs for the various groups are
ummarized in Table 5. Of note, patients with residual peak
S gradients 35 mm Hg and only mild AR had shorter
reedom from AVR than patients with moderate or severe
cute AR but peak residual AS 35 mm Hg, although the
ifference between these groups did not reach significance
HR: 1.6; 95% CI: 0.89 to 2.9; p  0.11).
solated native AS. Subgroup analysis of freedom from
VR and freedom from any aortic valve surgery was also
Figure 4 Freedom From Repeat Balloon Dilation
Kaplan-Meier curves depict estimated freedom from repeat balloon dilation
after the initial balloon valvuloplasty procedure in neonates and older patients
with congenital aortic stenosis.
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November 16, 2010:1740–9 Aortic Valve Reintervention in Congenital ASerformed for the 320 patients in the present cohort with
solated native AS (i.e., no associated cardiovascular anom-
lies, no prior aortic valve interventions). Freedom from
VR among patients with isolated native AS was 94  1%
t 5 years, 82  3% at 10 years, 68  4% at 15 years, and
7  5% at 20 years. Similar to the overall cohort, freedom
rom AVR and freedom from any aortic valve surgery
mong patients with isolated native AS were both longer in
atients with lower post-dilation gradients and less severe
Results of Univariate and Multivariate Cox Regrof Freed m From Any Aortic Valve Surgery and FTable 4 Results of Univari te and Multivariaof Freedom From Any Aortic Valve S
Predictor Variable
Univariate analysis
Procedure number quartile
First
Second
Third
Fourth
Age group
30 days
1–12 months
1-–10 yrs
11–15 yrs
16 yrs
Isolated native AS
Prior aortic valve intervention*
Multiple left-heart obstructive lesions
Pre-intervention peak AS gradient (10 mm Hg)
Acute post-intervention peak AS gradient (10 mm Hg)
Acute post-intervention peak AS gradient category (mm H
29
30–39
40
Acute post-intervention AR severity
None
Trace
Mild
Moderate or severe
Final multivariate model
Acute post-intervention peak AS gradient category (mm H
29
30–39
40
Acute post-intervention AR severity
None
Trace
Mild
Moderate or severe
Procedure number quartile
First
Second
Third
Fourth
Multiple left-heart obstructive lesions
*Surgical or transcatheter aortic valve intervention before balloon val
AR aortic regurgitation; AS aortic stenosis; AVR aortic valve reost-dilation AR. biscussion
n this long-term observational study, we followed 509 early
urvivors of balloon dilation for congenital AS for a median
f 9.3 years and a maximum of 23.6 years. There was an
ngoing steady hazard for AVR that was not associated with
ear or era of intervention, resulting in a freedom from AVR
f 79  3% at 10 years and 55  4% at 20 years. Not
urprisingly, acute post-dilation valve dysfunction, including
n Analysesom From AVRox Regres ion Analyses
ry and Freedom From AVR
Any Aortic Valve Surgery AVR
HR (95% CI) p Value HR (95% CI) p Value
Reference Reference
.87 (0.58–1.31) 0.51 0.74 (0.47–1.15) 0.18
.23 (0.79–1.92) 0.35 0.85 (0.50–1.45) 0.55
.57 (0.88–2.79) 0.13 0.68 (0.28–1.67) 0.40
.64 (0.35–1.17) 0.15 0.29 (0.14–0.58) 0.001
.47 (0.26–0.88) 0.017 0.25 (0.13–0.48) 0.001
.59 (0.33–1.05) 0.07 0.39 (0.22–0.71) 0.002
.76 (0.42–1.39) 0.38 0.59 (0.32–1.09) 0.09
Reference Reference
.58 (0.42–0.80) 0.001 0.67 (0.46–0.97) 0.034
.01 (1.37–2.94) 0.001 2.34 (1.52–3.59) 0.001
.57 (1.52–4.35) 0.001 1.94 (1.01–3.74) 0.046
.02 (0.94–1.10) 0.61 1.11 (1.01–1.21) 0.023
.27 (1.15–1.39) 0.001 1.26 (1.14–1.39) 0.001
Reference Reference
.32 (0.88–1.97) 0.18 1.36 (0.84–2.21) 0.21
.63 (1.83–3.79) 0.001 2.99 (1.96–4.57) 0.001
Reference Reference
.25 (0.75–2.10) 0.39 1.10 (0.57–2.10) 0.78
.85 (1.20–2.90) 0.006 2.34 (1.31–3.92) 0.001
.41 (2.76–7.04) 0.001 4.45 (2.55–7.77) 0.001
Reference Reference
.33 (0.88–2000) 0.18 1.65 (1.01–2.70) 0.046
.69 (1.85–3.93) 0.001 3.20 (2.07–4.94) 0.001
Reference Reference
.20 (0.71–2.02) 0.49 1.11 (0.58–2.14) 0.78
.98 (1.27–3.09) 0.003 2.48 (1.57–4.18) 0.001
.85 (3.03–7.77) 0.001 4.92 (2.80–8.65) 0.001
Reference Reference
.99 (0.65–1.52) 0.98 0.89 (0.57–1.42) 0.65
.26 (0.79–1.99) 0.34 0.95 (0.56–1.63) 0.85
.95 (1.07–3.56) 0.03 0.97 (0.39–2.43) 0.95
.42 (1.38–4.24) 0.001 NA
ty at our center.
ent; CI confidence interval; HR hazard ratio; NA not applicable.essioreedt C
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Aortic Valve Reintervention in Congenital AS November 16, 2010:1740–9ere the strongest risk factors for eventual AVR and were
ndependently associated with shorter freedom from AVR.
hese findings confirm that patients who undergo balloon
ilation for AS, regardless of age, AS severity, or associated
nterventions, are at ongoing risk for AVR, a finding that
hould inform the clinical care of such patients before and
fter treatment of congenital AS. There was a steady hazard
or death after a relatively steep acute phase hazard.
Risk factors for any aortic valve surgery were the same as
or AVR on multivariate analysis, with the addition of
ultiple left-heart obstructive lesions and balloon dilation
uring the most recent quartile of our experience. Era was
ot a significant predictor of shorter freedom from aortic
alve surgery on univariate analysis but was forced into the
ultivariate models in recognition of the changes in practice
hat inevitably occur over time. The finding on multivariate
nalysis that freedom from aortic valve surgery was shorter
Figure 5 Freedom From AVR
Kaplan-Meier curves depict freedom from aortic valve replacement (AVR) after ball
tion (N  neonate, M  months, Y  years), (B) history of prior aortic valve interv
40 mm Hg), and (D) severity of aortic regurgitation (AR) after balloon dilation (Nn the most recent quartile of patients undergoing balloon oalvuloplasty is almost certainly due to a change in practice
t our institution, with a more aggressive approach to aortic
alve repair for AR over the past decade (16). No similar era
ffect was observed for AVR.
In this study, we included patients with congenital AS
ho underwent balloon dilation at any age, as long as it was
erformed at our center, as well as patients with associated
ardiovascular anomalies and those who had undergone
rior aortic valve intervention elsewhere. On univariate Cox
egression analysis, isolated native AS, the absence of
ultiple left-heart obstructive lesions (2 of the following
lus AS: aortic coarctation, mitral stenosis, subaortic steno-
is), and no prior interventions for AS were associated with
onger freedom from AVR and/or from any aortic valve
urgery, but none of these variables were significant on
ultivariate analysis. In addition, in a subgroup analysis of the
20 patients with isolated native AS, there was only a modest
lation for congenital aortic stenosis (AS) according to (A) age at initial interven-
elsewhere, (C) residual AS gradient after balloon dilation (29, 30 to 39, or
e, T  trace, M  mild, S  moderate-severe).oon di
ention
 nonverall difference in freedom from AVR or surgery compared
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November 16, 2010:1740–9 Aortic Valve Reintervention in Congenital ASith patients with associated anomalies or prior interventions,
nd post-intervention AR and residual AS remained strong
redictors of freedom from reoperation. Thus, although the
ndings in our overall cohort may be modestly confounded by
he heterogeneity of the patient population, they reflect out-
omes in the more limited subset of patients with isolated
ative AS, indicating that the long-term aortic valve outcomes
re primarily a function of the underlying aortic valve disease
nd acute procedural outcomes.
The objective of this study was not to assess risk factors
or acute outcome, which have been characterized in previ-
us reports from our center and elsewhere (2,4,9–14).
evertheless, we did observe that the incidence of moderate
r severe AR was higher in patients who were older at the
ime of intervention and that there was no clear association
etween residual gradient and the severity of AR. Studies
ave shown that the risk for acute post-dilation AR is
igher with larger balloon/annular diameter ratios, with a
atio of 0.9:1 to 1.0:1 an important threshold (2,4,11).
owever, other investigators whose practice did not include
ny procedures in which the balloon/annulus ratio exceeded
.0:1 reported that below this threshold, the ratio was not
ssociated with risk for AR (10). Other studies have
uggested that aortic valve morphology, including the num-
er of valve leaflets and valve thickness, may contribute to
he risk for post-dilation AR as well (2,9). We and others
ave previously documented the tendency for AR to
rogress in severity over time after balloon dilation of
ongenital AS in neonates and older patients (10–12).
lthough the same analysis was not duplicated in this
ohort, the ongoing hazard of aortic valve reoperation in
his series supports that trend.
It is difficult to compare our findings with those of other
ecently published midterm to long-term follow-up studies
Figure 6 Freedom From AVR by Residual Valve Disease
Kaplan-Meier curves depict freedom from aortic valve replacement (AVR) after
balloon dilation for congenital aortic stenosis (AS) according to 6 empirical
groups of combined residual AS and aortic regurgitation (AR), defined as acute
residual AS gradient at catheterization 35 mm Hg (blue) or 35 mm Hg
(red) and AR as 0 to 1 (none or trivial), 2 (mild), or 3 to 4 (moderate-severe).f balloon dilation for congenital AS, such as those by Fratz
A
it al. (12) and Reich et al. (9). Those studies included early
eaths and analyzed reinterventions only as survival free
rom reintervention, neither of which was the case for our
tudy. Because there is a well-known early hazard for death
r conversion to single-ventricle circulation among new-
orns with AS, as well as improving early outcomes in this
ubset of patients in recent years (11), we elected to limit our
tudy to early survivors to focus more clearly on the issue of
ortic valve reintervention. Nevertheless, our findings do not
eem markedly discrepant from the 5- to 10-year results
eported by Fratz et al. (12) and Reich et al. (9) with respect to
verall freedom from aortic valve reintervention. Pedra et al. (8)
ollowed 87 children who underwent aortic valve dilation at6
onths of age for an average of 6.3 years and reported almost
o mortality, 67% freedom from aortic valve reintervention at
years, and 46% freedom from reintervention at 12 years.
igher post-dilation gradient, significant post-dilation AR,
nd symmetric valve opening were associated with increased
isk for aortic valve reintervention. Again, our findings are not
ramatically different from those in that cohort.
In many respects, neonatal or critical AS is a different
isease from congenital AS treated later in life. Clearly, the
ortality risk is higher in newborns with symptomatic AS
han in older infants, children, and adolescents or adults
9,12). We have previously reported acute and longer term
utcomes in neonates treated with balloon aortic valvulo-
lasty (11,13) and did not explore that patient population in
etail in this study. The primary reason for including
eonates in this series was to assess the relative burden of
eintervention over time, compared with patients who
ndergo dilation at an older age. Not surprisingly, we found
hat patients who underwent balloon dilation in the first
onth of life had a significantly higher hazard for repeat
alloon dilation. As discussed in earlier reports, 1 of the top
riorities in neonates with symptomatic AS is to provide
ufficient relief of the left ventricular outflow obstruction to
llow ventricular recovery and stable circulation, while
voiding severe AR. Thus, our tolerance for residual AS is
elatively high in this cohort. Moreover, growth velocity is
igher in newborns than older patients, and recurrent AS
ay be more likely to manifest in association with rapid
atient growth. Despite the higher hazard for repeat balloon
Rs for AVR Among Patientsith Different C mbin o s ofo t- ilatio Residual AS and Acute AR
Table 5
H s for AVR Am ng Patients
With Different Combinations of
Post-Dilation Residual AS and Acute AR
Residual Peak
AS Gradient
(mm Hg) Acute Post-Dilation AR HR (95% CI) p Value
35 None-trivial Reference
Mild 1.8 (0.99–3.2) 0.054
Moderate-severe 4.2 (2.3–7.7) 0.001
35 None-trivial 2.0 (1.1–4.0) 0.036
Mild 6.3 (3.5–11.1) 0.001
Moderate-severe 9.9 (4.8–20.4) 0.001R  aortic regurgitation; AS  aortic stenosis; AVR  aortic valve replacement; CI  confidence
nterval; HR  hazard ratio.
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Aortic Valve Reintervention in Congenital AS November 16, 2010:1740–9ilation, patients initially treated for AS in the newborn
eriod were at no higher risk for aortic valve surgery in
eneral or AVR in particular than older patients.
A common and potentially important dilemma in pa-
ients undergoing balloon dilation for congenital AS at the
ime of the procedure is what balance to strike between
esidual AS and procedural AR. This question is particularly
hallenging when the gradient is between 30 and 40 mm Hg
nd there is trivial or mild AR. The balance of acute residual
S and AR after the procedure clearly has ramifications for
uture risk for aortic valve reintervention and AVR, but may
ake years to become manifest. Using a combined acute
emodynamic outcome variable, patients with residual AS
radients 35 mm Hg in general had longer freedom from
VR than those with gradients 35 mm Hg, and those
ith less significant AR had longer freedom from AVR
han those with more severe AR. However, patients with
esidual AS gradients 35 mm Hg and only mild AR had
horter freedom from AVR than patients with less residual
S but more severe AR (p  0.11), suggesting that
eduction of AS below 35 mm Hg may be more important
han previously recognized and may be indicated even at the
xpense of mild or greater AR. This analysis was not
djusted or stratified for age, and it is possible that the
bserved patterns do not hold true for particular age groups.
tudy limitations. The primary limitations of this study
ere the retrospective study design and extended enrollment
eriod, logistic considerations that may limit the applicabil-
ty of our findings. Similarly, although there were general
linical guidelines, there were no standardized criteria for
eferral for catheterization or balloon dilation, or for defin-
ng a procedural end point, and practice likely varied over
ime and among practitioners. In analyses of freedom from
eintervention, we considered only baseline and acute post-
ntervention variables and as such cannot account for the
otential contributions of later developments or subacute or
hronic changes in valve function or patient status. Also,
any of the patients in this cohort were primarily followed
lsewhere. Criteria for AVR or other reinterventions on the
ortic valve may have varied within this population accord-
ng to a variety of factors. Differences in clinical decision
aking around surgical reintervention in older and younger
atients may have confounded our analysis. For instance, by
nivariate analysis, freedom from AVR was shorter in older
atients. This may have been due in part to the higher
ncidence of significant acute AR in older patients (possibly
ue to operators’ being more aggressive in their attempts to
elieve obstruction in this population, in whom AVR can be
ore readily undertaken than in younger patients) but also
o a lower threshold for replacing the aortic valve in larger
atients, in whom the risks of operation may be lower (17)
nd who are less likely to require reintervention for upsizing
f the aortic valve prosthesis or, in the case of the Ross
rocedure, right ventricular outflow conduit (18). Also, for
ogistical reasons, we did not assess serial aortic valve
unction or the potential impact of evolving AR or outflowbstruction on freedom from reintervention. Because our
rimary focus was aortic valve reintervention, and certain
uestions relating to survival in this cohort are the focus of
nother ongoing study, our analysis of survival was limited.
onclusions
lthough balloon aortic valvuloplasty is highly effective for
cute relief of congenital AS, there are steady long-term
azards for surgical aortic valve reintervention and for AVR
hat are independent of age at balloon dilation and severity
f presenting AS. Although neonates are at higher risk for
epeat balloon dilation, they are at no higher risk for AVR
han older patients. These findings should inform counsel-
ng and evaluation of patients before and after treatment of
ongenital AS.
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